January 27, 2020
Thermo Fisher Scientific Unveils $6 Million Expansion at Viral Vector Manufacturing Facility

Photo:

Thermo Fisher Scientific Unveils $6 Million Expansion at Viral Vector Manufacturing Facility

Investment doubles the site's process development capabilities and establishes commercial testing

| 11/22/2019

ALACHUA COUNTY, Fla (November 22, 2019) – Thermo Fisher Scientific, the world leader in serving science, today unveiled the $6 million expansion of its gene therapy and viral vector services site in Alachua, Florida. The investment doubles the site’s laboratory and warehousing capacity for upstream process development and quality control testing of gene therapy products.

The expansion at the Alachua facility is part of Thermo Fisher’s $270 million investment this year to expand its capabilities, capacity and talent globally to enable its customers to develop and deliver high quality medicines to patients around the world. This investment follows the company’s recent acquisition of Brammer Bio, a leader in viral vector manufacturing.

“The team at our Alachua site has more than12 years of expertise developing processes, analytics and manufacturing GMP materials to help our customers with clinical development of advanced medicines for rare and complex diseases,” said Chris Murphy, vice president and general manager, viral vector services at Thermo Fisher. “This investment in Alachua  signifies our continued commitment to serve our gene therapy customers and their patients in need.” 

“Thermo Fisher’s investment to expand here in Alachua highlights our reputation as a destination for the biotech industry,” said Eric Godet, CEO of the Greater Gainesville Chamber of Commerce. “As the company continues to grow to serve their customers around the globe with medical advancements, so do the economic and workforce opportunities for our community.”

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with revenues of more than $24 billion and approximately 70,000 employees globally. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics, deliver medicines to market and increase laboratory productivity. Through our premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services – we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive services. For more information, please visit www.thermofisher.com.

For information about how we process personal data, please visit our privacy policy at https://fleishmanhillard.com/privacy-policy-general/ and our privacy policy applicable to the European Economic Area at https://fleishmanhillard.com/gdpr-privacy-policy/.

Tags: Press Release

Digital Access

DIRECT DIGITAL ACCESS
Add digital to your current subscription, purchase a single digital issue, or start a new subscription to Florida Trend.

TABLE OF CONTENTS
An overview of the features and articles in this month's issue of Florida Trend.

ACCESS THIS ISSUE »

Florida Business News

Florida Trend Video Pick

Dementia-friendly dining debuts in Florida
Dementia-friendly dining debuts in Florida

An Orlando-area Italian restaurant is taking on a unique new mission. The Meatball Stoppe says it is about to become the only dementia-friendly restaurant in Central Florida. 

Earlier Videos | Viewpoints@FloridaTrend

Ballot Box

Should life insurance companies be allowed to deny policies or set premiums based on an individual's genetic test results?

  • Yes
  • No
  • Need more information
  • Indifferent/no opinion
  • Other

See Results

Florida Trend Media Company
490 1st Ave S
St Petersburg, FL 33701
727.821.5800

© Copyright 2020 Trend Magazines Inc. All rights reserved.